World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC), 60243-60244 [2021-23684]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 208 / Monday, November 1, 2021 / Notices
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2021–23652 Filed 10–29–21; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2021–0118; NIOSH 248–
I]
World Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP STAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, CDC
announces the following virtual meeting
for the World Trade Center Health
Program Scientific/Technical Advisory
Committee (WTCHP STAC). A notice of
this WTCHP STAC meeting has also
been posted on the committee website
at: https://www.cdc.gov/wtc/stac_
meeting.html.
SUMMARY:
The meeting will be held on
November 18, 2021, from 11:00 a.m. to
4:00 p.m., EST. Comments must be
received by November 18, 2021. Written
public comment received prior to the
meeting will be part of the official
record of the meeting.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2021–
0118; NIOSH 248–I by mail. CDC does
not accept comments by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Docket number CDC–2021–
0118; NIOSH 248–I, c/o Sherri Diana,
NIOSH Docket Office, National Institute
for Occupational Safety and Health,
1090 Tusculum Avenue, MS C–34,
Cincinnati, Ohio 45226.
Instructions: All submissions received
must include the Agency name and
Docket Number (CDC–2021–0118;
NIOSH 248–I). All relevant comments,
including any personal information
provided, will be posted without change
to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D.,
Designated Federal Officer, World Trade
Center Health Program, National
Institute for Occupational Safety and
Health, CDC, 1600 Clifton Road NE, MS
lotter on DSK11XQN23PROD with NOTICES1
DATES:
VerDate Sep<11>2014
18:03 Oct 29, 2021
Jkt 256001
R–12, Atlanta, GA 30329–4027,
Telephone: (513) 841–4515; Email: wtcstac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The WTCHP STAC was
established by Title I of the James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347 (Jan.
2, 2011), as amended by Public Law
114–113 (Dec. 18, 2015) and Public Law
116–59 (Sept. 27, 2019), adding Title
XXXIII to the Public Health Service
(PHS) Act (codified at 42 U.S.C. 300mm
to 300mm–61).
Purpose: The purpose of the WTCHP
STAC is to review scientific and
medical evidence and to make
recommendations to the Administrator
of the World Trade Center (WTC) Health
Program regarding additional WTC
Health Program eligibility criteria,
potential additions to the List of WTCRelated Health Conditions (List), and
research regarding certain health
conditions related to the September 11,
2001, terrorist attacks.
Title XXXIII of the PHS Act
established the WTC Health Program
within the Department of Health and
Human Services (HHS). The WTC
Health Program provides medical
monitoring and treatment benefits to
eligible firefighters and related
personnel, law enforcement officers,
and rescue, recovery, and cleanup
workers who responded to the
September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001 or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors). Certain specific
activities of the Administrator of the
WTC Health Program are reserved to the
Secretary, HHS, to delegate at his
discretion; other duties not explicitly
reserved to the Secretary, HHS, are
assigned to the Director of the National
Institute for Occupational Safety and
Health (NIOSH). The administration of
the WTCHP STAC is left to the Director
of NIOSH in his role as Administrator.
CDC and NIOSH provide funding,
staffing, and administrative support
services for the WTCHP STAC. The
charter was reissued on May 12, 2021
and will expire on May 12, 2023.
Matters To Be Considered: The agenda
will include a presentation about
revisions to the existing Policy and
Procedures for Adding Types of Cancer
to the List of WTC-Related Health
Conditions, a report from the STAC
workgroup regarding adding uterine
cancer to the List, deliberations by the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
60243
full committee on the STAC
recommendation to the Administrator of
the WTC Health Program on whether to
add uterine cancer to the List, and
recommendations on peer reviewers to
review the evaluation of the evidence
for adding the health condition to the
List. The revised draft Policy and
Procedures for Adding Types of Cancer
to the List of WTC-Related Health
Conditions is available on the WTC
Health Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
An agenda is also posted on the WTC
Health Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
Agenda items are subject to change as
priorities dictate.
Meeting Information: This is a virtual
meeting conducted via Zoom. The
public is welcome to follow the
proceedings via live webcast. No
registration is required. The webcast
link for November 18, 2021 is https://
www.ustream.tv/channel/
QyXBRzYjVCS. For additional
information please visit the WTC Health
Program website at https://
www.cdc.gov/wtc/stac_meeting.html.
Public Participation
Interested parties may participate in
this activity by submitting written
views, opinions, recommendations, and
data. You may submit comments on any
topic related to this activity. Comments
received, including attachments and
other supporting materials, are part of
the public record and subject to public
disclosure. Do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
CDC does not accept comment by email.
Oral Public Comment: The public is
welcome to participate, via Zoom,
during the public comment period on
November 18, 2021, from 1:00 p.m. to
1:30 p.m., EST. Please note that the
public comment period ends at the time
indicated above. Each commenter will
be provided up to five minutes for
comment. A limited number of time
slots are available and will be assigned
on a first come-first served basis.
E:\FR\FM\01NON1.SGM
01NON1
lotter on DSK11XQN23PROD with NOTICES1
60244
Federal Register / Vol. 86, No. 208 / Monday, November 1, 2021 / Notices
Members of the public who wish to
address the WTCHP STAC during the
oral public comment sessions must sign
up by providing their name to Mia
Wallace, Committee Management
Specialist, via email: MWallace@
cdc.gov, or the addresses section
provided in this notice by November 12,
2021.
Written Public Comment: Written
comments will also be accepted per the
instructions provided in the addresses
section above. Written public comment
received prior to the meeting will be
part of the official record of the meeting.
The docket will close on November 18,
2021.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to https://www.regulations.gov within 60
days after the meeting. If a person
making a comment gives their name, no
attempt will be made to redact that
name. NIOSH will take reasonable steps
to ensure that individuals making
public comments are aware that their
comments (including their name, if
provided) will appear in a transcript of
the meeting posted on a public website.
Such reasonable steps include a
statement read at the start of the meeting
stating that transcripts will be posted,
and names of speakers will not be
redacted. If individuals in making a
statement reveal personal information
(e.g., medical information) about
themselves, that information will not
usually be redacted. The CDC Freedom
of Information Act coordinator will,
however, review such revelations in
accordance with the Freedom of
Information Act and, if deemed
appropriate, will redact such
information. Disclosures of information
concerning third party medical
information will be redacted.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Medicare & Medicaid
Services
Notice of Closed Meeting
[Document Identifiers CMS–1557 and CMS–
370G–I]
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2021–23684 Filed 10–29–21; 8:45 am]
[FR Doc. 2021–23732 Filed 10–29–21; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
VerDate Sep<11>2014
18:03 Oct 29, 2021
Jkt 256001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
PAR 20–312, State Occupational Safety
and Health Surveillance Program (U60).
Date: January 25, 2022.
Time: 1:00 p.m.–5:00 p.m., EST.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Dan
Hartley, Ed.D., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational
Safety and Health, CDC, 1095
Willowdale Road, Morgantown, West
Virginia 26505, Telephone: (304) 285–
5812; Email: DHartley@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by December 1, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Website address at
Website address at: https://
www.cms.gov/Regulations-andGuidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
SUMMARY:
E:\FR\FM\01NON1.SGM
01NON1
]]>Agencies
[Federal Register Volume 86, Number 208 (Monday, November 1, 2021)]
[Notices]
[Pages 60243-60244]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-23684]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0118; NIOSH 248-I]
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, CDC
announces the following virtual meeting for the World Trade Center
Health Program Scientific/Technical Advisory Committee (WTCHP STAC). A
notice of this WTCHP STAC meeting has also been posted on the committee
website at: https://www.cdc.gov/wtc/stac_meeting.html.
DATES: The meeting will be held on November 18, 2021, from 11:00 a.m.
to 4:00 p.m., EST. Comments must be received by November 18, 2021.
Written public comment received prior to the meeting will be part of
the official record of the meeting.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0118; NIOSH 248-I by mail. CDC does not accept comments by email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Docket number CDC-2021-0118; NIOSH 248-I, c/o Sherri
Diana, NIOSH Docket Office, National Institute for Occupational Safety
and Health, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226.
Instructions: All submissions received must include the Agency name
and Docket Number (CDC-2021-0118; NIOSH 248-I). All relevant comments,
including any personal information provided, will be posted without
change to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
Designated Federal Officer, World Trade Center Health Program, National
Institute for Occupational Safety and Health, CDC, 1600 Clifton Road
NE, MS R-12, Atlanta, GA 30329-4027, Telephone: (513) 841-4515; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Background: The WTCHP STAC was established by Title I of the James
Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111-347
(Jan. 2, 2011), as amended by Public Law 114-113 (Dec. 18, 2015) and
Public Law 116-59 (Sept. 27, 2019), adding Title XXXIII to the Public
Health Service (PHS) Act (codified at 42 U.S.C. 300mm to 300mm-61).
Purpose: The purpose of the WTCHP STAC is to review scientific and
medical evidence and to make recommendations to the Administrator of
the World Trade Center (WTC) Health Program regarding additional WTC
Health Program eligibility criteria, potential additions to the List of
WTC-Related Health Conditions (List), and research regarding certain
health conditions related to the September 11, 2001, terrorist attacks.
Title XXXIII of the PHS Act established the WTC Health Program
within the Department of Health and Human Services (HHS). The WTC
Health Program provides medical monitoring and treatment benefits to
eligible firefighters and related personnel, law enforcement officers,
and rescue, recovery, and cleanup workers who responded to the
September 11, 2001, terrorist attacks in New York City, at the
Pentagon, and in Shanksville, Pennsylvania (responders), and to
eligible persons who were present in the dust or dust cloud on
September 11, 2001 or who worked, resided, or attended school,
childcare, or adult daycare in the New York City disaster area
(survivors). Certain specific activities of the Administrator of the
WTC Health Program are reserved to the Secretary, HHS, to delegate at
his discretion; other duties not explicitly reserved to the Secretary,
HHS, are assigned to the Director of the National Institute for
Occupational Safety and Health (NIOSH). The administration of the WTCHP
STAC is left to the Director of NIOSH in his role as Administrator. CDC
and NIOSH provide funding, staffing, and administrative support
services for the WTCHP STAC. The charter was reissued on May 12, 2021
and will expire on May 12, 2023.
Matters To Be Considered: The agenda will include a presentation
about revisions to the existing Policy and Procedures for Adding Types
of Cancer to the List of WTC-Related Health Conditions, a report from
the STAC workgroup regarding adding uterine cancer to the List,
deliberations by the full committee on the STAC recommendation to the
Administrator of the WTC Health Program on whether to add uterine
cancer to the List, and recommendations on peer reviewers to review the
evaluation of the evidence for adding the health condition to the List.
The revised draft Policy and Procedures for Adding Types of Cancer to
the List of WTC-Related Health Conditions is available on the WTC
Health Program website at https://www.cdc.gov/wtc/stac_meeting.html. An
agenda is also posted on the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html. Agenda items are subject to change
as priorities dictate.
Meeting Information: This is a virtual meeting conducted via Zoom.
The public is welcome to follow the proceedings via live webcast. No
registration is required. The webcast link for November 18, 2021 is
https://www.ustream.tv/channel/QyXBRzYjVCS. For additional information
please visit the WTC Health Program website at https://www.cdc.gov/wtc/stac_meeting.html.
Public Participation
Interested parties may participate in this activity by submitting
written views, opinions, recommendations, and data. You may submit
comments on any topic related to this activity. Comments received,
including attachments and other supporting materials, are part of the
public record and subject to public disclosure. Do not include any
information in your comment or supporting materials that you consider
confidential or inappropriate for public disclosure. If you include
your name, contact information, or other information that identifies
you in the body of your comments, that information will be on public
display. CDC will review all submissions and may choose to redact, or
withhold, submissions containing private or proprietary information
such as Social Security numbers, medical information, inappropriate
language, or duplicate/near duplicate examples of a mass-mail campaign.
CDC will carefully consider all comments submitted into the docket. CDC
does not accept comment by email.
Oral Public Comment: The public is welcome to participate, via
Zoom, during the public comment period on November 18, 2021, from 1:00
p.m. to 1:30 p.m., EST. Please note that the public comment period ends
at the time indicated above. Each commenter will be provided up to five
minutes for comment. A limited number of time slots are available and
will be assigned on a first come-first served basis.
[[Page 60244]]
Members of the public who wish to address the WTCHP STAC during the
oral public comment sessions must sign up by providing their name to
Mia Wallace, Committee Management Specialist, via email:
[email protected], or the addresses section provided in this notice by
November 12, 2021.
Written Public Comment: Written comments will also be accepted per
the instructions provided in the addresses section above. Written
public comment received prior to the meeting will be part of the
official record of the meeting. The docket will close on November 18,
2021.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person
making a comment gives their name, no attempt will be made to redact
that name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware that their comments (including their
name, if provided) will appear in a transcript of the meeting posted on
a public website. Such reasonable steps include a statement read at the
start of the meeting stating that transcripts will be posted, and names
of speakers will not be redacted. If individuals in making a statement
reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and, if
deemed appropriate, will redact such information. Disclosures of
information concerning third party medical information will be
redacted.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-23684 Filed 10-29-21; 8:45 am]
BILLING CODE 4163-18-P
